Group One Trading
RNAC icon

Group One Trading’s Cartesian Therapeutics RNAC Stock Holding History

Group One Trading’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,000
Closed -$10.2K – 9009
2025
Q3 		$10.2K Hold
1,000
– – ﹤0.01% 7149
2025
Q2 		$10.4K Buy
+1,000
New +$10.7K ﹤0.01% 6694
2024
Q3 		– Sell
-3,900
Closed -$105K – 7262
2024
Q2 		$105K Buy
3,900
+3,603
+1,213% +$86K ﹤0.01% 3924
2024
Q1 		$5.79K Buy
297
+27
+10% +$572 ﹤0.01% 6123
2023
Q4 		$5.57K Sell
270
-2,027
-88% -$60.5K ﹤0.01% 6463
2023
Q3 		$73K Sell
2,297
-823
-26% -$27.5K ﹤0.01% 4749
2023
Q2 		$105K Buy
3,120
+2,320
+290% +$83K ﹤0.01% 4579
2023
Q1 		$33.4K Buy
+800
New +$37.6K ﹤0.01% 5164
2022
Q4 		– Sell
-2,073
Closed -$102K – 7967
2022
Q3 		$102K Buy
2,073
+2,000
+2,740% +$110K ﹤0.01% 4761
2022
Q2 		$3K Sell
73
-1,797
-96% -$53.3K ﹤0.01% 7325
2022
Q1 		$69K Sell
1,870
-1,783
-49% -$112K ﹤0.01% 5849
2021
Q4 		$357K Sell
3,653
-1,720
-32% -$185K ﹤0.01% 4494
2021
Q3 		$671K Buy
5,373
+76
+1% +$9.18K ﹤0.01% 3872
2021
Q2 		$664K Sell
5,297
-1,426
-21% -$170K ﹤0.01% 3901
2021
Q1 		$913K Buy
6,723
+4,116
+158% +$511K ﹤0.01% 3347
2020
Q4 		$237K Buy
2,607
+834
+47% +$72.3K ﹤0.01% 3935
2020
Q3 		$132K Buy
1,773
+1,343
+312% +$103K ﹤0.01% 3981
2020
Q2 		$37K Buy
430
+270
+169% +$24.5K ﹤0.01% 4538
2020
Q1 		$12K Buy
+160
New +$15.4K ﹤0.01% 4492
2019
Q1 		– Sell
-7
Closed -$1K – 5282
2018
Q4 		$1K Buy
7
+4
+133% +$913 ﹤0.01% 4743
2018
Q3 		$2K Sell
3
-104
-97% -$41.8K ﹤0.01% 5031
2018
Q2 		$42K Buy
+107
New +$38K ﹤0.01% 4046

Other funds holding RNAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Group One Trading's RNAC Position: Q2 2024 in Review

Group One Trading sold out of Cartesian Therapeutics (RNAC) in Q2 2024, closing a stake of 94 shares — an estimated $2.24K sold.

Group One Trading first reported a position in RNAC in Q3 2018 and held it in 19 quarters. The position peaked at $348K in Q2 2021. 61 funds tracked by Wall St. Rank hold RNAC as of Q2 2024.

  • Group One Trading reported no remaining Cartesian Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Group One Trading sold 94 Cartesian Therapeutics shares in Q2 2024, an estimated $2.24K.
  • Group One Trading first reported a position in Cartesian Therapeutics in Q3 2018 and held it in 19 quarters.
  • Group One Trading's Cartesian Therapeutics position peaked at $348K in Q2 2021.
  • 61 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q2 2024.

Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.